Necrotizing myopathy associated with TET2-mutated myelodysplastic syndrome

QJM. 2022 Sep 22;115(9):633-634. doi: 10.1093/qjmed/hcac144.

Authors

T Dietrich¹, D de Mornac¹, A Garnier², A Espitia¹, A Néel¹, A Normand³, C Toquet^{3

4}, C Agard¹

Affiliations

¹ Department of Internal Medicine, Nantes University Hospital, Nantes, France.
² Department of Haematology, Nantes University Hospital, Nantes, France.
³ Department of Pathology, Nantes University Hospital, Nantes, France.
⁴ Institut du Thorax, INSERM, Nantes, F-44000, France.

PMID: 35689623
DOI: 10.1093/qjmed/hcac144

No abstract available

MeSH terms

DNA-Binding Proteins / genetics
Dioxygenases*
Humans
Muscular Diseases* / genetics
Mutation
Myelodysplastic Syndromes* / complications
Myelodysplastic Syndromes* / genetics
Proto-Oncogene Proteins / genetics

Substances

DNA-Binding Proteins
Proto-Oncogene Proteins
Dioxygenases
TET2 protein, human